Prolonged extrapyramidal symptoms induced by long‐term, intermittent administration of low‐dose olanzapine along with metoclopramide for emesis: A case report
Abstract Background Antipsychotics with dopamine (D2) receptor antagonism can be effective for emesis in cancer patients. Extrapyramidal symptoms (EPS) induced by typical antipsychotics can be exacerbated by other D2 receptor antagonists. We describe a case of persistent EPS induced by long‐term, in...
Main Authors: | Shoko Sakamoto, Yasuhiko Deguchi, Sawako Uchida, Yoshiaki Itoh, Koki Inoue |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2022-09-01
|
Series: | Neuropsychopharmacology Reports |
Subjects: | |
Online Access: | https://doi.org/10.1002/npr2.12277 |
Similar Items
-
Metoclopramide in Gastroparesis: Its Mechanism of Action and Safety Profile
by: M Ammar Kalas, et al.
Published: (2023-08-01) -
METOCLOPRAMIDE – INDUCED EXTRAPYRAMIDAL SIGNS AND SYMPTOMS – BRIEF REVIEW OF LITERATURE AND CASE REPORT.
by: Mirena Valkova, et al.
Published: (2014-11-01) -
Ifosfamide-induced extrapyramidal neurotoxicity with COVID-19
by: Chitrakshi Nagpal, et al.
Published: (2023-01-01) -
Extrapyramidal symptoms as a consequence of organophosphate poisoning: Insights from a clinical case
by: J. Martins Correia, et al.
Published: (2021-04-01) -
Comparison of metoclopramide–dexamethasone combination and metoclopramide alone for prophylaxis of postoperative nausea vomiting in laparoscopic cholecystectomy
by: Humaira Ahmad, et al.
Published: (2023-02-01)